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Abstract. Basically, progesterone enzyme immunoassay is based on the principle of competitive 
binding between progesterone in the test specimen and progesterone-enzyme conjugate for a constant amount of 
rabbit anti-progesterone. Primary antiserum, raised on rabbit against progesterone and secondary antiserum, 
raised on sheep against rabbit IgG, are evaluated regarding total protein, gamma globulins and titre variations, 
using capillary electrophoresis and immunodiffusion test. In both rabbit and sheep, immunizations were followed 
by a constant rise in total protein, gamma globulin concentrations and titre values, too, so that the obtained 
antisera were freeze dried for further characterization and use in the enzyme immunoassay for serum 
progesterone. 
 
INTRODUCTION 
 
Progesterone is a C21 steroid which is synthesized from both tissue and circulating 
cholesterol.  Cholesterol is transformed to pregnenolone which is then converted via a 
combined dehydrogenase and isomerase to progesterone.  The principle production sites are 
the ovaries, the placenta during pregnancy and the adrenals.  The majority of this steroid is 
metabolized in the liver to pregnane-diol and conjugated as a glucuronide prior to excretion 
by the kidneys.   
Progesterone exhibits a wide variety of end organ effects. The primary role of 
progesterone is exhibited by the reproductive organs. In females, progesterone could represent 
an indicator for pregnancy, presence of luteal tissue as a consequence of ovulation (cow) or, 
the presence of LH surge and imminent ovulation (bitch). Progesterone measurements are 
thus performed to determine ovulation as well as to characterize luteal phase disorders.  
Monitoring of progesterone therapy and early stage pregnancy evaluations comprise the 
remaining uses of progesterone assays. 
In males, progesterone is a necessary intermediate for the production of corticosteroids 
and androgens. 
According to the increasing frequency of reproductive disorders in cow and also in 
companion pets and mainly to the crucial role of progesterone, we decided to develop our 
own serum progesterone immunoassay, as a tool for diagnosis and treatment of above 
mentioned disorders. This enzyme immunoassay is based on the principle of competitive 
binding between progesterone in the test specimen and progesterone-HRP conjugate for a 
constant amount of rabbit anti-progesterone. We have generated our own primary antiserum, 
raised on rabbit against a progesterone conjugate and also secondary antiserum, raised on 
sheep against rabbit IgG. The aim of this paper is to present the results obtained in the process 
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of evaluation of both antisera, regarding total protein, gamma globulins and titre variations, 
using capillary electrophoresis and immunodiffusion test. 
 
MATERIALS  AND  METHODS 
 
There were used three female rabbits (common breed) for group 1  and also three for 
group 2, separately housed, fed at libitum. Females were subcutaneously injected with 
Progesterone 3-(O-Carboxymethyl)-oxime BSA fluorescein isothiocyanate conjugate (SIGMA 
Aldrich P8779), mixed with Freund`s Complete Adjuvant (FCA) for the first shot, than with 
Incomplete Freund`s Incomplete Adjuvant (FCI) for boosters, as mentioned in table 1. As 
long as progesterone molecule is no table to generate alone an immune response, it was 
necessary its binding to a carrier protein, represented in our case by BSA (bovine serum 
albumin). 
 
Table 1. Immunization schedule in rabbit 
 12th of June 
2006 
10th of July 
2006 
24th of July 
2006 
7th of August 
2006 
21st of 
August 06 
Group 1 100 µg + FCA 50 µg + FCI 50 µg + FCI 50 µg + FCI 50 µg + FCI 
Group 2 300 µg + FCA 150 µg + FCI 150 µg + FCI 150 µg + FCI 150 µg + FCI 
 
For immunization of female in group 2 we have used the protocole recommended by 
Szafranska et al (2002), as long as in group 1, the schedule and doses which we considered to 
be optimal. Blood was sampled two weeks before first immunization (considered as initial 
value, for control – first sample), after the first immunization (antigen plus FCA – second 
sample ), after last booster (antigen plus FCI – last sample), and 6 weeks after the last booster 
(final). Total proteins and gamma globulins were assayed from serum through Beckman 
capillary electrophoresis, on Paragon CZE 2000. From each group was selected the female 
expressing the highest values of total protein (rabbit “B” from G1 and rabbit “D” from G2) 
and antibody titre was determined by the method of Sewell (1967), using immunodiffusion, 
and expressed as the mg of antigen precipitated by 1 ml of antiserum at equivalence. 
The sheep were housed together, fed ad libitum. The two groups consisted of three 
sheep each. It was used Rabbit IgG – Agarose Purified Immunoglobulin (SIGMA A2909), 
together with Freund`s Adjuvant Complete (FCA), SIGMA F5881 for the first immunization, 
or with Freund`s Adjuvant Incomplete (FCI), SIGMA F5506, for the next four boosters. The 
mixture was intradermal administered, in 10-12 different injection sites, 4 centimeter apart 
one of each other, on the lateral side of sheep`s neck, previously shaved and disinfected. The 
second booster followed first administration after 30 days, the other boosters coming at 15 
days interval (table 2). 
 
 
Table 2. Sheep immunization using Rabbit IgG – Agarose Purified Immunoglobulin 
 12th of June  
2006 
10th of July 
2006 
24th of July 
2006 
7th of August 
2006 
21st of August 
2006 
Group 1 250 µg + FCA 100 µg + FCI 100 µg + FCI 100 µg + FCI 100 µg + FCI 
Group 2 1000 µg + FCA 500 µg + FCI 500 µg + FCI 500 µg + FCI 500 µg + FCI 
 
In group 2 we have used the doses recommended by Szafranska et al (2002), and in 
group 1, the doses we considered to be optimal. Blood sampling, total protein and gamma 
globulins assay followed the same pattern described in rabbits. Based on the highest values of 
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total protein, sheep nr. 729 (G1) and sheep nr. 970 (G2) were choosen for antibody titre assay, 
using the same method. 
 
RESULTS AND DISCUSSIONS 
 
As results from tables 3 and 4, it was registered a rising trend for total protein and 
gamma globulins values, and tires too, for both rabbits and sheep. 
In rabbits, the total protein concentrations registered at 6 weeks after final booster, 
exceeded physiological range (BSAVA Manual for Exotic Pets – 2002) for both females. 
Female “D”, belonging to group immunized with higher doses, displayed a superior value, 
compared to rabbit “B”. 
 
Table 3. Characteristics of primary antisera, raised on rabbit against progesterone 
 
 Rabbit “B” Rabbit   “D” 
Sampling First Second Last Final First Second Last Final 
Total proteins 
(g/l) 
61.53 64.46 62.33 76.20 62.20 64.70 66.20 80.40 
Gamma 
globulins (g/l) 
6,10 6,60 6,40 7,40 5,83 6,21 7,21 8,19 
Titre (mg/ml) - 0.26 0.60 0.80 - 0.67 0.94 1.30 
 
Table 4. Characteristics of secondary antisera, raised on sheep against rabbit IgG 
 
 Sheep nr. 729 Sheep nr. 970 
Sampling First Second Last Final First Second Last Final 
Total proteins 
(g/l) 
78.13 80.20 83.60 88.60 84.20 88.30 90.20 93.06 
Gamma 
globulins (g/l) 
26.30 28.02 29.16 31.10 34.61 36.77 39.26 41.60 
Titre (mg/ml) - 0.41 1.08 1.28 - 0.62 1.44 1.81 
 
It has long been known that progesterone (PRG) and its derivates are able to modulate a 
variety of immune responses (Grossman -1984, Hansen -1998). In fact, the ability of 
progesterone to suppress cell-mediated functions has been considered of great relevance for 
the maintenance of pregnancy. Thus, high levels of progesterone found in the human placenta 
may promote survival of the fetal allograft by inhibiting maternal lymphocyte responses 
(Szekeres-Bartho et al., 1990). While suppressive effects of PRG on cellular functions are 
well-established, its effects on antibody production are much less clear. Administration of 
PRG to animals has been shown to reduce or have no effects on humoral response to T-
dependent antigens. However, more recent data in vitro demonstrated that PRG functions as a 
potent inducer of T helper 2 (Th2) type cytokines which might favour the development of 
antibody responses (Piccinini et al., 1995). 
The results of Vermeulen et al. (2001) showed  that the in vivo administration of 
medroxyprogesterone acetate (MPA) to mice, 7 or 90 days before immunization with sheep 
red blood cells, significantly enhanced both, primary and secondary antibody responses, 
without affecting delayed-type hypersensitivity . These effects could be counteracted by the 
anti-progestin onapristone (ZK 98299) suggesting that MPA interacted with progesterone 
receptors to increase B-cell response. 
In our study, a similar pattern to that displayed by total proteins was followed by gamma 
globulins, and most important, by antibodies titres, rising finally to 0,80 mg/ml (rabbit “B”) 
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and 1,30 mg/ml (rabbit “D”). Further investigations will reveal antibodies specificity and 
affinity. Progesterone is a small and non-immunogenic molecule and hence it was necessary 
to conjugate it to a carrier protein to make it immunogenic. BSA is widely used as the carrier 
protein to prepare the immunogen. Regarding the position on the progesterone molecule that 
was selected for the formation of bridge, there is a debate regarding the use of the 11 position, 
or 3 position concerning subsequent affinity. Samuel et al (2006) reported that titres improved 
with the boosters, when progesterone 11 alpha hemmisuccinate BSA was used for rabbit 
immunization. 
For sheep (table 4), the final value of total protein was greater in sheep immunized with 
larger dose, ranging above physiological accepted values (Ghergariu et al, 2000). The same 
ascending trend was registered for both gamma globulins and antibodies titres, proving a 
correlation between the levels of total proteins, gamma globulins and antibody titre (Figure 1). 
It is widely accepted that a high antibody titre generates a strong affinity and specificity. The 
evolution of gamma globulins resembles the changing registered subsequent to various 
immunization.  
 
Figure nr.1 Evolution of antibodies titres in primary and secondary antisera (mg/ml). For this chart only, 
values were multiplied by ten, for a better view. 
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Chen et al (2000) reported that Cholera (and related) toxins administered in water or 
intramusculary induce systemic immune responses in sheep. After immunization, IgG, IgG1 
and IgG2 antibody in immunized groups were significantly higher than in the control group, 
and boosting further increased these titres. A persistent (nine weeks post infestation) rise in 
IgG1 levels was reported by Raadsma et al (2007), subsequent to experimental infection with 
Fasciola gigantica or Fasciola hepatica in Merinos sheep, while IgG1 level remained 
unchanged in controls. IgG1 remained at a high level for 12 to 14 weeks (depending on dose) 
after experimental infestation of sheep with Psoroptes ovis (Siegfried et al, 2004). 
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CONCLUSIONS 
 
Immunization protocol using higher doses of antigen generated superior concentrations 
of total proteins and gamma globulins and also higher antibody titres in both sheep and 
rabbits. 
Although during immunization protocol total proteins and gamma globulins ranged in 
physiologically admitted values, at six weeks after final booster, their values exceeded the 
superior accepted limit, in both rabbits and sheep. 
It was emphasized a positive correlation between total protein concentration and titres in 
primary and secondary antisera generated for progesterone immunoassay. 
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